Ibrutinib, Nivolumab and Blinatumomab in Richter Transformation
Clinical trial NCT03121534 · TERMINATED
Trial details
- NCT number
- NCT03121534
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-22
- Primary completion
- 2022-02-11
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.